Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 2658 to 2707 of 3228 in total 
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2658\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
b-cell lymphoma 3-encoded protein (bcl-3 protein). [source:swissprot;acc:p20749]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8278.73\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8211.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00824\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2659\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear factor nf-kappa-b p105 subunit (dna-binding factor kbf1) (ebp- 1) [contains: nuclear factor nf-kappa-b p50 subunit]. [source:swissprot;acc:p19838]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8277.7\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8210.29\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00821\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2660\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nf-kappab inhibitor beta (nf-kappa-bib) (i-kappa-b-beta) (ikappabbeta) (ikb-beta) (ikb-b) (thyroid receptor interacting protein 9) (tr- interacting protein 9). [source:swissprot;acc:q15653]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8277.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8210.21\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2661\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear factor nf-kappa-b p100/p49 subunits (h2tf1) (oncogene lyt-10) (lyt10) [contains: nuclear factor nf-kappa-b p52 subunit]. [source:swissprot;acc:q00653]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8277.66\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8210.26\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2662\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dj408b20.3 (novel protein similar to 60s acidic ribosomal protein p2 (rplp2)). [source:sptrembl;acc:q9h5a9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4300.46\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4334.66\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00795\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2663\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
microtubule-actin crosslinking factor 1, isoform 4. [source:swissprot;acc:q96pk2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4608.54\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4576.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00703\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2664\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
bullous pemphigoid antigen 1 isoforms 1/2/3/4/5/8 (230 kda bullous pemphigoid antigen) (bpa) (hemidesmosomal plaque protein) (dystonia musculorum protein) (fragment). [source:swissprot;acc:q03001]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4608.91\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4576.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00702\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2665\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
anaphase promoting complex subunit 11 (hepatocellular carcinoma associated ring finger protein) (hspc214). [source:swissprot;acc:q9nyg5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8936.97\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8999.55\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.007\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2666\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dyskerin (nucleolar protein nap57) (cbf5 homolog). [source:swissprot;acc:o60832]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4591.08\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4621.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00671\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2667\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna-directed rna polymerase ii 7.6 kda polypeptide (ec 2.7.7.6) (rpb10) (rpb7.6) (rpabc5). [source:swissprot;acc:p52436]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4071.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4099.01\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00666\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2668\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
iron-responsive element binding protein 1 (ire-bp 1) (iron regulatory protein 1) (irp1) (ferritin repressor protein) (aconitate hydratase) (ec 4.2.1.3) (citrate hydro-lyase) (aconitase). [source:swissprot;acc:p21399]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8222.61\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8169.38\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00652\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2669\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dipeptidyl peptidase 8 isoform 2; dipeptidyl peptidase 8. [source:refseq;acc:nm\_017743]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4336.58\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4310.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0061\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2670\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dipeptidylpeptidase 9; dipeptidyl peptidase 9; dipeptidyl peptidase iv-related protein-2. [source:refseq;acc:nm\_139159]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4336.62\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4310.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00609\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2671\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
muscle-specific beta 1 integrin binding protein. [source:refseq;acc:nm\_014446]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4338.79\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4313.52\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00586\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2672\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-specific protease otubain 2. [source:refseq;acc:nm\_023112]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7350.69\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7390.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00541\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2673\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l22 (epstein-barr virus small rna associated protein) (eber associated protein) (eap) (heparin binding protein hbp15). [source:swissprot;acc:p35268]\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
7780.98\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7741.14\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00515\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2674\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sin3 associated polypeptide p30; sin3-associated polypeptide, 30kd. [source:refseq;acc:nm\_003864]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2675\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
clathrin coat assembly protein ap50 (clathrin coat associated protein ap50) (plasma membrane adaptor ap-2 50 kda protein) (ha2 50 kda subunit) (clathrin assembly protein complex 2 medium chain) (ap-2 mu 2 chain). [source:swissprot;acc:p20172]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2676\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
atp-binding cassette, sub-family c, member 10; multidrug resistance-associated protein 7. [source:refseq;acc:nm\_033450]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2677\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lysosomal alpha-mannosidase precursor (ec 3.2.1.24) (mannosidase, alpha b) (lysosomal acid alpha-mannosidase) (laman) (mannosidase alpha class 2b member 1). [source:swissprot;acc:o00754]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2678\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rna polymerase i transcription factor rrn3. [source:refseq;acc:nm\_018427]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2679\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rho guanine nucleotide exchange factor 6 (pak-interacting exchange factor alpha) (alpha-pix) (cool-2). [source:swissprot;acc:q15052]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5358.78\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5384.44\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00479\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2680\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine-protein kinase pak 3 (ec 2.7.1.-) (p21-activated kinase 3) (pak-3) (beta-pak) (oligophrenin-3). [source:swissprot;acc:o75914]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5358.3\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5383.94\vspace{3pt}}}&\\\cline{1-3}\cline{5-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2681\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine-protein kinase pak 2 (ec 2.7.1.-) (p21-activated kinase 2) (pak-2) (pak65) (gamma-pak) (s6/h4 kinase). [source:swissprot;acc:q13177]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5358.31\vspace{3pt}}&&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00478\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2682\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
conserved oligomeric golgi complex subunit 5 (13s golgi transport complex 90 kda subunit) (gtc-90) (golgi transport complex 1). [source:swissprot;acc:q9up83]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5358.3\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5383.93\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2683\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine-protein kinase pak 1 (ec 2.7.1.-) (p21-activated kinase 1) (pak-1) (p65-pak) (alpha-pak). [source:swissprot;acc:q13153]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2684\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rho guanine nucleotide exchange factor 7 (pak-interacting exchange factor beta) (beta-pix) (cool-1) (p85). [source:swissprot;acc:q14155]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5357.73\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5383.33\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2685\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytochrome c1, heme protein, mitochondrial precursor (cytochrome c-1). [source:swissprot;acc:p08574]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
3953.53\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
3972.32\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00475\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2686\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
oligophrenin-1 like protein (gtpase regulator associated with focal adhesion kinase). [source:swissprot;acc:q9una1]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2687\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
senescence marker protein-30 (smp-30) (regucalcin) (rc). [source:swissprot;acc:q15493]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2688\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
oligophrenin 1. [source:swissprot;acc:o60890]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2689\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuropilin- and tolloid-like protein 2 precursor. [source:refseq;acc:nm\_018092]\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4113.79\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4095.53\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00446\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2690\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
neuropilin- and tolloid-like protein 1 isoform 3 precursor. [source:refseq;acc:nm\_138966]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2691\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heterogenous nuclear ribonucleoprotein u (hnrnp u) (scaffold attachment factor a) (saf-a). [source:swissprot;acc:q00839]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2692\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
runt-related transcription factor 2 (core-binding factor, alpha 1 subunit) (cbf-alpha 1) (acute myeloid leukemia 3 protein) (oncogene aml-3) (polyomavirus enhancer binding protein 2 alpha a subunit) (pebp2-alpha a) (pea2-alpha a) (sl3-3 enhancer factor 1 alpha a subunit) (sl3/akv core-binding factor alpha a subunit) (osteoblast- specific transcription factor 2) (osf-2). [source:swissprot;acc:q13950]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2693\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
e1b-55kda-associated protein 5 isoform a. [source:refseq;acc:nm\_007040]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2694\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60s ribosomal protein l18. [source:swissprot;acc:q07020]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2695\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
endonuclease g, mitochondrial precursor (ec 3.1.30.-) (endo g). [source:swissprot;acc:q14249]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5176.92\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5154.43\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00436\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2696\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
programmed cell death protein 8, mitochondrial precursor (ec 1.-.-.-) (apoptosis-inducing factor). [source:swissprot;acc:o95831]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2697\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
t-box transcription factor tbx6 (t-box protein 6). [source:swissprot;acc:o95947]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2698\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
trub pseudouridine (psi) synthase homolog 1. [source:refseq;acc:nm\_139169]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4163.36\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4145.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0042\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2699\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heterogeneous nuclear ribonucleoprotein m (hnrnp m). [source:swissprot;acc:p52272]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5356.83\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5378.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00399\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2700\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
short coiled-coil protein; short coiled coil protein. [source:refseq;acc:nm\_032547]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5239.33\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5260\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00395\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2701\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dynein light chain 2. [source:refseq;acc:nm\_080677]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2702\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
creatine kinase, sarcomeric mitochondrial precursor (ec 2.7.3.2) (s- mtck) (mib-ck) (basic-type mitochondrial creatine kinase). [source:swissprot;acc:p17540]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8971.66\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9006.92\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00393\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2703\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
creatine kinase, ubiquitous mitochondrial precursor (ec 2.7.3.2) (u- mtck) (mia-ck) (acidic-type mitochondrial creatine kinase). [source:swissprot;acc:p12532]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8972.87\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9007.71\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00388\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2704\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
creatine kinase, m chain (ec 2.7.3.2) (m-ck). [source:swissprot;acc:p06732]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8980.12\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9013.33\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0037\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2705\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein cgi-27 (c21orf19-like protein). [source:swissprot;acc:q9y316]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4137.61\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4152.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00365\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2706\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
peptidyl prolyl isomerase h; cyclophilin h. [source:refseq;acc:nm\_006347]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
8979.61\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
9012.31\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00364\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2707\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
prp18 pre-mrna processing factor 18 homolog. [source:refseq;acc:nm\_003675]\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/